Apoglyx Competitors and Similar CompaniesClear all
Apoglyx's competitors and similar companies include Carmot Therapeutics and BIOTON.
 Apoglyx Apoglyx is a biotech company developing a small molecule oral therapy for type 2 diabetes patients. |  Carmot Therapeutics Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer. | ||
Founding Date | Founding Date 2015 | Founding Date 2008 | Founding Date 1989 |
Type | Type Private | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Malmö, SE HQ Lund, SE | Locations Berkeley, US HQ | Locations Macierzysz, PL HQ |
Employees | Employees 525% increase | Employees 109% decrease | Employees 361 |
Financial | |||
Net income | Net income N/A | Net income ($38.8m) (FY, 2022) | Net income zł3.4m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Carmot Therapeutics
HQ
Berkeley, US
Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer.
View company
BIOTON
HQ
Macierzysz, PL
Employees
361
Bioton is a biotech company whose major therapeutic area is diabetes.
View company